These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2155092)

  • 1. Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
    Sidwell RW; Huffman JH; Schafer TW; Shipman C
    Chemotherapy; 1990; 36(1):58-69. PubMed ID: 2155092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model.
    Shipman C; Smith SH; Drach JC; Klayman DL
    Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
    Freeman DJ; Sacks SL; De Clercq E; Spruance SL
    Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir treatment of experimental genital herpes simplex virus infections.
    Kern ER
    Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice.
    Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW
    J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
    Lee PH; Su MH; Kern ER; Higuchi WI
    Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
    Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
    J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection.
    Spruance SL; McKeough MB; Cardinal JR
    Antimicrob Agents Chemother; 1984 Jan; 25(1):10-5. PubMed ID: 6703671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships among alpha-(N)-heterocyclic acyl thiosemicarbazones and related compounds as inhibitors of herpes simplex virus type 1-specified ribonucleoside diphosphate reductase.
    Turk SR; Shipman C; Drach JC
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1625-32. PubMed ID: 3016157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
    Collins P; Oliver NM
    Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
    Richards JT; Kern ER; Overall JC; Glasgow LA
    Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
    McKeough MB; Spruance SL
    Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1985 Jul; 28(1):103-6. PubMed ID: 4037770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic efficacy of a xanthate compound on herpes simplex virus in skin lesions of mice and guinea-pigs.
    Amtmann E; Hummel K; Sauer G
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1953-60. PubMed ID: 2993486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
    Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
    Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections.
    Sheridan J; Kern E; Martin A; Booth A
    Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.